3-hydroxy-2-[hydroxy(methoxy)methyl]-7,9-dimorpholin-4-ylpyrido[1,2-a]pyrimidin-4-one
C18H24N4O6 — CID 123615856
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-hydroxy-2-[hydroxy(methoxy)methyl]-7,9-dimorpholin-4-ylpyrido[1,2-a]pyrimidin-4-one
3-hydroxy-2-[hydroxy(methoxy)methyl]-7,9-dimorpholin-4-ylpyrido[1,2-a]pyrimidin-4-one (PubChem CID 123615856) has the molecular formula C18H24N4O6 and a molecular weight of 392.41 g/mol. Its IUPAC name is 3-hydroxy-2-[hydroxy(methoxy)methyl]-7,9-dimorpholin-4-ylpyrido[1,2-a]pyrimidin-4-one.
Molecular Properties
| Compound Name | 3-hydroxy-2-[hydroxy(methoxy)methyl]-7,9-dimorpholin-4-ylpyrido[1,2-a]pyrimidin-4-one |
|---|---|
| PubChem CID | 123615856 |
| Molecular Formula | C18H24N4O6 |
| Molecular Weight | 392.41 g/mol |
| Exact Mass | 392.17 |
| IUPAC Name | 3-hydroxy-2-[hydroxy(methoxy)methyl]-7,9-dimorpholin-4-ylpyrido[1,2-a]pyrimidin-4-one |
| SMILES | COC(O)c1nc2c(N3CCOCC3)cc(N3CCOCC3)cn2c(=O)c1O |
| InChI | InChI=1S/C18H24N4O6/c1-26-18(25)14-15(23)17(24)22-11-12(20-2-6-27-7-3-20)10-13(16(22)19-14)21-4-8-28-9-5-21/h10-11,18,23,25H,2-9H2,1H3 |
| InChIKey | RNBXCTUQZIQYHW-UHFFFAOYSA-N |
| XLogP | -0.29 |
| TPSA | 109.00 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 392.41 |
| LogP ≤ 5 | -0.29 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123615856 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.